Barclays analyst issues UNDERWEIGHT recommendation for BMY on October 7, 2024 06:41AM ET. The previous analyst recommendation was Underweight.BMY was trading at $53.96 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues EQUAL-WEIGHT recommendation for AMZN on October 7, 2024 05:09AM ET. The previous analyst recommendation was Underperform.AMZN was trading at $186.51 at issue of the analyst recommendation.The...
Barclays analyst issues UNDERWEIGHT recommendation for NFLX on October 7, 2024 04:59AM ET. The previous analyst recommendation was Equal-Weight.NFLX was trading at $719.7 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues UNDERPERFORM recommendation for AFRM on October 4, 2024 10:00AM ET. The previous analyst recommendation was Underperform.AFRM was trading at $38.18 at issue of the analyst recommendation.The overall...
Wedbush analyst issues SECTOR PERFORM recommendation for AFRM on October 4, 2024 10:00AM ET. The previous analyst recommendation was Sector Perform.AFRM was trading at $38.18 at issue of the analyst...
Wedbush analyst issues SECTOR PERFORM recommendation for AFRM on October 4, 2024 10:00AM ET. The previous analyst recommendation was Sector Perform.AFRM was trading at $38.18 at issue of the analyst...
Susquehanna analyst issues UNDERPERFORM recommendation for AFRM on October 4, 2024 10:00AM ET. The previous analyst recommendation was Underperform.AFRM was trading at $38.18 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues OUTPERFORM recommendation for EQT on October 4, 2024 08:39AM ET. The previous analyst recommendation was Outperform.EQT was trading at $37.67 at issue of the analyst recommendation.The...
BMO Capital analyst issues MARKET PERFORM recommendation for XOM on October 4, 2024 08:40AM ET. The previous analyst recommendation was Market Perform.XOM was trading at $122.58 at issue of the...
BMO Capital analyst issues OUTPERFORM recommendation for CVE on October 4, 2024 08:41AM ET. The previous analyst recommendation was Outperform.CVE was trading at $17.84 at issue of the analyst recommendation.The...
